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Considerable evidence has accumulated indicating that the leukemic lympho- 
cytes  of patients  with  chronic  lymphatic  leukemia  (CLL)  carry  surface  im- 
munoglobulin  (Ig) of a  single light- and heavy-chain class and that the heavy 
chain  is  usually  IgM  (1-3).  This  has  been  taken  as  evidence  of  the  mono- 
clonality  of  the  proliferating  cells.  Recently  it  has  been  reported  that  IgD 
represents  the surface Ig of a  significant number of normal human peripheral 
blood lymphocytes (4,  5).  Of special significance has been the study of Rowe 
et  al.  (6)  demonstrating  that  most  normal  lymphocytes  bearing  IgM  also 
have IgD  on their surface. It appeared of special interest  to study IgD in the 
monoclonal CLL situation  and determine its relationship  to the usual  surface 
IgM that is present. The findings indicate that the majority of CLL cases have 
leukemic cells with IgD as well as IgM on their surface. In addition, free light 
chains were frequently found. 
Materials and Methods 
Anti-Immunoglobulin Antisera.--Antisera against  isolated  IgM, IgG, IgA, IgD, Fab  of 
Fraction  II human T-globulin  (Fr II), and  kappa and lambda Bence Jones proteins  were 
raised in New Zealand Red rabbits. For immunofluorescence, all antisera conjugated with tet- 
ramethylrhodamine  isothioeyanate  according to Amante et al.  (7)  were absorbed  with  an 
agammaglobulinemic serum bound to the Sepharose 4B gel activated by cyanogen bromide. 
The anti-# antiserum  (Rho-anti-#)  was further absorbed with Sepharose-bound Fr II, the 
anti-'~, (Rho-anti-~,) with Sepharose-bound IgM, IgA, Bence Jones kappa and lambda  pro- 
teins,  the anti-a  (Rho-anti-a)  with Sephaxose-bound Fr II, IgM, Bence Jones  kappa and 
lambda proteins, and the anti-6  (Rho-anti-~) with Sepharose-bound Fr II, IgM lambda and 
IgA lambda  myeloma proteins.  The anti(Fab)-'y-serum  (Rho-anti-Fab)  was  not absorbed 
further. Antiserum specificities were ascertained by double diffusion and direct hemagghltina- 
tion. The Rho-anti-#,  Rho-anti-%  Rho-anti-ot, and Rho-anti-~ gave a single precipitin  line 
with normal human sera. The Rho-anti-/z agglutinated  only IgM-coated red cells, the Rho- 
anti-')'  only IgG-coated  red  cells, the Rho-anti-o~ only IgA-coated  red cells, and the Rho- 
anti-~ only IgD-coated red ceils. The Rho-anfi  Fab had activities  against  both kappa and 
lambda  determinants.  When  the  Rho-anti-Fab was  absorbed  with  Sepharose-bound  IgG 
lambda, or IgG kappa, it was specific for kappa or lambda determinants. 
For hemagglutination  inhibition, the anti-# antiserum after absorption with Fr II ag~ati- 
nated IgM-coated red cells and this  agglutination  inhibited  only by either  igM kappa or 
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IgM lambda proteins. The anti-6 antiserum was absorbed with Fr II and a normal serum with 
low levels of IgD. After absorption, it was specific for ~-determinants only. Similar absorptions 
and specificity experiments were done with the anti-T and anti-or antisera. Anti-kappa Bence 
Jones antisera were absorbed with purified pooled whole human T-globulin or human sera. 
After this absorption, the antisera were specific for free kappa chain only. Similar absorptions 
were done with the anti-lambda antisera. An anti-Fr II llght-chain antiserum (anti-Fr II-L) 
was a  generous gift from Dr.  W. Epstein of the University of California at San Francisco. 
This antiserum was used after absorption with whole myeloma proteins and a normal human 
serum. 
Lymphocyte Separation.--Mononuclear cells were isolated from  the peripheral  blood of 
chronic lymphocytic leukemia patients by Ficoll-Hypaque discontinuous gradients. The ceils 
were washed six times with 50 ml phosphate-buffered saline  (PBS).  For hemagglutination 
inhibition, ceils were suspended in the concentration of  1-2  X  108 ceils/ml.  For immuno- 
fluorescence, 0.5-1  X  107 ceUs/ml suspensions were made. Viability of all lymphocyte prepa- 
rations was greater than 95% b~ trypan blue exclusion. 
Immunofluorescence.--Immunofluorescent  staining  of  lymphocyte  surface  Ig  was  per- 
formed as described by Pernis et al.  (8). For each preparation,  100--400 ceils were counted. 
Antisera were routinely centrifuged to remove agegrgates before use. Absorption of the Rho- 
anti-/z  by  Sepharose-linked IgM,  the  Rho-anti-T  by  Sepharose-bound IgG  (purified from 
Fr  II  by  DEAE  column  chromatography),  the Rho-anti-a  by  Sepharose-bound IgA,  the 
Rho-anti-Fab by Sepharose-bound IgG and the Rho-anti-6 by an isolated IgD myeloma pro- 
tein removed the staining activities of these anfisera. In these experiments, the blocking pro- 
teins used were different from the immunizing proteins. 
Hemagglutination and Hemagglutination Inkibition.--IIemaggintination  and hemagglutina- 
tion inhibition experiments were carried out as  described previously  (9).  Purified proteins 
were coated onto human red cells by the bisdiazotized benzidine method (BDB). A lymphocyte 
suspension was incubated with an equal volume of appropriately diluted antisera for 45 rain 
and after centrifugation, 0.1 ml of the supernate was used to test its ability to agglutinate 
indicator red cells.  More than 90-95% lymphoeytes were viable after absorption. By com- 
parison of the inhibition  efficiency of the cell suspensions in serial dilutions and known amount 
of inhibitory proteins, the gross amount of surface Ig was estimated. 
Initially, considerable difficulty was encountered in applying hemagglutination technique 
to  estimate  lymphccyte  surface IgM.  This was  overcome by  applying antisera of  highly 
limited specificities for certain regions of the/z chain. Details of this method will be described 
elsewhere. 
RESULTS 
Surface Ig of CLL Lymphocytes.--Both  IgM and IgD  were  found on  the 
surface  of CLL lymphocytes as shown by representative cases A, B, C, and D 
(Table  I). The Rho-anti-Fab antiserum measured the total percentage of Ig- 
TABLE  I 
Lymphocyte Surface Ig of Representative CLL Cases 
Immunofluorescence 
Patient 
IgM  IgD  Fab  Kappa  Lambda 
%  %  %  %  % 
A  88  89  94  6  86 
B  73  67  74  70  2 
C  12  87  93  6  93 
D  80  3  86  83  2 PU~  WINCHESTER~  KUNKEL  BRIEF  DEFINITIVE  REPORT  453 
bearing cells in these patients  since the antiserum had both anti-kappa  and 
anti-lambda activities. In the first two instances (A and B) the majority of the 
Ig-bearing lymphocytes were stained with both the Rho-anti-/z and the Rho- 
anti-& Since these antisera were highly specific for/z or ~-determinants it was 
apparent from the percentages stained that the vast majority of cells bore both 
IgM and IgD on their surface. In the third instance (C) IgM was not detectable 
by fluorescence except in a small number of cells which represented at least in 
part normal B cells in the sample. No significant number of ~,- and o~-bearing 
lymphocytes were found in these cases. A total of 15 CLL cases were studied 
and in 10 a high percentage of the cells showed IgD ; in most instances IgM was 
found as well on the same high percentage of cells. Four cases showed IgM and 
not IgD; three showed IgD and not IgM; one showed low percentages of IgM, 
IgD,  and Fab. In all the cases studied there was predominantly one class of 
light chains on lymphocytes of an individual CLL patient. The pattern of stain- 
ing by these three rhodamine-conjugated antisera was finely granular.  How- 
ever, the intensities  of lymphocyte staining by these  antisera varied among 
different patients.  In  general, when  IgM  and  IgD  were both present,  Rho- 
anti-~ and Rho-anti-~ stained with similar intensities. 
Considerable experience has been gained recently in the use of hemagglutina- 
tion inhibition techniques for obtaining semiquantitative information on sur- 
face Igs onlymphocytes. This method has the advantage of applying antisera of 
clearly defined specificity as determined by experiments such as those shown in 
Table II. In three cases in Table I, IgD was readily detected on the lympho- 
cyte surface in quantities that clearly related the IgD  to the leukemic cells. 
IgM was detectable similarly in cases A and B but barely so in case C. No IgG 
or IgA were detected in any of the cases. In case C, lambda determinants were 
found and no kappa determinants were detected. In  all  respects the results 
were similar to those obtained by fluorescence. 
Detection of Free Light Chains on CLL Lymphocytes.--It is known that anti- 
sera can be made to light chains that detect determinants that are hidden when 
light  chains  exist in combination with heavy chains in  whole proteins  (11). 
Such antisera were prepared to both kappa and lambda Bence-Jones proteins 
and after absorption showed such "free chain" specificity. Table II illustrates 
TABLE II 
Specificity of Anti-Kappa Chain Serum Absorbed with Normal Human Serum 
Inhibitor protein concentration (mg/ml) 
1  0.1  0.01  0.001  0.0001  0.00001 
Kappa Bence Jones  0 
Lambda Bence Jones  2 
IgG K  tr 
IgM K  2 
Normal human serum (diluted 1/10)  2 
0  0  0  0  2 
2  2  2  2  2 
2  2  2  2  2 
2  2  2  2  2 
2  2  2  2  2 
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this point. Only kappa Bence-Jones proteins inhibited the agglutination of the 
kappa protein coated red cells by the  antiserum whereas  whole  IgG kappa, 
IgM kappa, and normal human sera did not inhibit the agglutination. Similar 
specificity only for free lambda  chains  was  also  obtained from anti-lambda 
Bence-Jones antisera. The anti-Fr ILL had specificities for both free kappa and 
lambda chains. 
When these hemagglutination inhibition systems were applied to the quanti- 
tation of free light chains on  CLL lymphocytes, lymphocytes of seven CLL 
patients were found to have readily detectable amounts of free light chain on 
their surface (Table III). The range of free light chains was between 125-1,000 
ng per  108 cells.  Free light chains were found on both kappa-  and  lambda- 
TABLE III 
Daection of Free Light Chains on CLL Lymphocyte Surface 
Patient  Class of light chain  Free light chain* 
ng/lO s  cells 
E  Kappa  1,000 
F  Kappa  500 
G  Kappa  250 
H  Kappa  125 
I  Kappa  125 
J  Lambda  250 
K  Lambda  250 
* Approximate values from the semiquantitative hemagglutination inhibition technique. 
bearing CLL lymphocytes. Determination of the total light chains on the same 
CLL cells by the usual anti-kappa and anti-lambda antisera with specificities 
against light chain determinants shared by both free chains and those in com- 
bination with heavy chains, indicated that the free light chains represented a 
significant portion of the total. In only one of eight cases studied were the free 
light chains undetectable. 
DISCUSSION 
In view of the monoclonal nature of the proliferating CLL cells with only a 
single class of light chains, these cells are proving extremely useful for studying 
the characteristics of a homogeneous cell population. Their B-cell nature with 
high percentages of Ig-bearing  cells is  now  firmly established  in  almost  all 
cases (3). The findings that the majority of CLL lymphocytes carry both IgD 
and IgM on their surface offers strong supportive evidence for the conclusions 
of Rowe et al. (6) from their studies on normal human lymphocytes. Pernis and 
Rowe have also  observed IgD  on leukemic lymphocytes recently) Evidence 
was obtained in the present study as well as the previous one (6) that the IgM 
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and IgD  are formed by the cells themselves and are not taken up from the 
serum. The single  light-chain type for each leukemia,  with both kappa  and 
lambda represented, offers strong evidence on this point. It also indicates that 
both the IgD and IgM have similar light chains. It appears probable that they 
also possess identical V regions and should share the same idiotypic specificity. 
This is currently under investigation. 
The significance of the free light chains on the leukemia cells remains to be 
determined. The use of antisera specific for the free chains determinants offered 
a  simple procedure for their detection. It remains to be determined whether 
similar amounts are found on normal B cells. More quantitative procedures for 
the light chains as well as for IgM and IgD are required to answer questions 
such as this. Evidence for some free surface light chains has been obtained in 
single instances previously by other methods (11, 12). 
15  CLL cases were investigated in the present study and it was  apparent 
from both fluorescence and hemagglutination inhibition studies that IgD was 
present on the surface of the leukemia cells in most but not all cases. In three 
instances the IgD was present in a high percentage of cells without detectable 
IgM. The major question concerning the presence of both Igs on these B cells 
is their relationship with  respect to receptor function. This question remains 
unanswered but it appears clear that  IgD must play a key role. 
SUMMARY 
An analysis  was made of the immunogiobulin surface  markers of the cells  of 
patients  with chronic lymphatic leukemia (CLL) in view of previous evidence 
of their  monoclonal B-cell  character.  The simultaneous presence of IgM and 
IgD on the surface  of the majority of lymphocytes was demonstrated by both 
immunofluorescence and hemagglutination inhibition  in most cases.  However, 
cases  were observed with surface IgM without IgD as well as cases  with IgD 
without IgM. IgG and IgA were absent.  Studies of the light  chains  indicated 
only a single  class  in a given case. In addition  to bound light  chains,  free  light 
chains were readily  demonstrated in most cases  through the use of antisera 
specific  for "free  chain" determinants. It thus appeared that there  are three 
major types  of  surface  Ig  on CLL lymphocytes, IgM, IgD, and free  light  chains. 
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